These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15096799)

  • 1. Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care.
    Abdool-Karim SS; Abdool-Karim Q; Friedland G; Lalloo U; El-Sadr WM;
    AIDS; 2004 Apr; 18(7):975-9. PubMed ID: 15096799
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settings.
    Harries AD; Chimzizi R; Zachariah R
    Lancet; 2006 Mar; 367(9514):944-5. PubMed ID: 16546545
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of antituberculosis treatment on virological response to highly active antiretroviral therapy: implications for resource-limited settings?
    Lawn SD; Wood R
    J Infect Dis; 2006 Nov; 194(10):1467-8; author reply 1468. PubMed ID: 17054078
    [No Abstract]   [Full Text] [Related]  

  • 4. Translational medicine as implementation science in the field of monitoring HIV and TB. New concepts emanating from resource-poor countries.
    Janossy G; Mandy F
    Cytometry B Clin Cytom; 2010 May; 78(3):183-7. PubMed ID: 20419763
    [No Abstract]   [Full Text] [Related]  

  • 5. Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?
    Lucas GM; Flexner CW; Moore RD
    AIDS Patient Care STDS; 2002 Nov; 16(11):527-35. PubMed ID: 12513901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating tuberculosis in AIDS patients: when to start and how long to keep giving drugs?
    Pedral-Sampaio DB; Netto EM; Brites C; Badaró R
    AIDS; 2002 Sep; 16(13):1845. PubMed ID: 12218406
    [No Abstract]   [Full Text] [Related]  

  • 7. TB and HIV: joint problems, joint solutions?
    Elzinga G; Nunn P
    Bull World Health Organ; 2002; 80(6):469-70. PubMed ID: 12132004
    [No Abstract]   [Full Text] [Related]  

  • 8. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study.
    Herce ME; Morse J; Luhanga D; Harris J; Smith HJ; Besa S; Samungole G; Kancheya N; Muyoyeta M; Reid SE
    BMC Infect Dis; 2018 Oct; 18(1):536. PubMed ID: 30367622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review.
    Uyei J; Coetzee D; Macinko J; Guttmacher S
    Lancet Infect Dis; 2011 Nov; 11(11):855-67. PubMed ID: 22035614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.
    Friedland G; Abdool Karim S; Abdool Karim Q; Lalloo U; Jack C; Gandhi N; El Sadr W
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S421-8. PubMed ID: 15156433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis and HIV Coinfection.
    Bruchfeld J; Correia-Neves M; Källenius G
    Cold Spring Harb Perspect Med; 2015 Feb; 5(7):a017871. PubMed ID: 25722472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
    Kwara A; Flanigan TP; Carter EJ
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of integrated treatment for tuberculosis and HIV in children at the primary health care level.
    Patel MR; Yotebieng M; Behets F; Vanden Driessche K; Nana M; Van Rie A
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1206-11. PubMed ID: 23827656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston.
    Behforouz HL; Farmer PE; Mukherjee JS
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S429-36. PubMed ID: 15156434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of integrated tuberculosis and human immunodeficiency virus service delivery on patient outcomes.
    Uyei J; Coetzee D; Macinko J; Weinberg SL; Guttmacher S
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):315-21. PubMed ID: 24670569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two diseases, same person: moving toward a combined HIV and tuberculosis continuum of care.
    Granich R; Gupta S
    Int J STD AIDS; 2018 Aug; 29(9):873-883. PubMed ID: 29629649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment.
    Corbett EL; Marston B; Churchyard GJ; De Cock KM
    Lancet; 2006 Mar; 367(9514):926-37. PubMed ID: 16546541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating HIV testing and care into tuberculosis services in Benin: programmatic aspects.
    Ferroussier O; Dlodlo RA; Capo-Chichi D; Boillot F; Gninafon M; Trébucq A; Fujiwara PI
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1402-4. PubMed ID: 24125441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missed opportunities for accessing HIV care among Tshwane tuberculosis patients under different models of care.
    Louwagie G; Girdler-Brown B; Odendaal R; Rossouw T; Johnson S; Van der Walt M
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1052-8. PubMed ID: 22691870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of antiretroviral drugs during tuberculosis therapy.
    Wilson D; Meintjes G
    N Engl J Med; 2010 Jun; 362(22):2137; author reply 2138-9. PubMed ID: 20519688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.